Parametric Portfolio Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.11M | Sell |
|
|||||
|
2021
Q4 | $4.33M | Sell |
|
|||||
|
2021
Q3 | $4.77M | Buy |
|
|||||
|
2021
Q2 | $4.38M | Sell |
|
|||||
|
2021
Q1 | $9.55M | Sell |
|
|||||
|
2020
Q4 | $13.8M | Buy |
|
|||||
|
2020
Q3 | $7.27M | Buy |
|
|||||
|
2020
Q2 | $3.36M | Buy |
|
|||||
|
2020
Q1 | $1.47M | Buy |
|
|||||
|
2019
Q4 | $1.21M | Buy |
|
|||||
|
2019
Q3 | $989K | Buy |
|
|||||
|
2019
Q2 | $1.27M | Buy |
|
|||||
|
2019
Q1 | $1.34M | Buy |
|
|||||
|
2018
Q4 | $685K | Sell |
|
|||||
|
2018
Q3 | $1.55M | Buy |
|
|||||
|
2018
Q2 | $1.47M | Buy |
|
|||||
|
2018
Q1 | $911K | Sell |
|
|||||
|
2017
Q4 | $1.02M | Buy |
|
|||||
|
2017
Q3 | $716K | Sell |
|
|||||
|
2017
Q2 | $863K | Sell |
|
|||||
|
2017
Q1 | $2.22M | Buy |
|
|||||
|
2016
Q4 | $1.72M | Sell |
|
|||||
|
2016
Q3 | $2M | Buy |
|
|||||
|
2016
Q2 | $1.11M | Sell |
|
|||||
|
2016
Q1 | $1.92M | Buy |
|
|||||
|
2015
Q4 | $1.03M | Sell |
|
|||||
|
2015
Q3 | $903K | Buy |
|
|||||
|
2015
Q2 | $836K | Buy |
|
|||||
|
2015
Q1 | $442K | Buy |
|